AIAI
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Unavailable or mixed. No liquidity or margin figures stored
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Pulls against a bullish reading. Interesting trend — weekly bias down
ACHAT TOTAL: 48 762 titres (~184 605,50 $ US)
- Insiders
- Affeldt EricRemy Donald Michael
- Total bought
-
$184,606
Avg buy (VWAP, 90d window) $4.47 vs last close $3.64 (-18.5%)
- Total sold
-
—
Avg sell (VWAP, 90d window) $14.11 vs last close $3.64 (-74.2%)
- Last activity
- 2026-09-22
- Liquidity
- Thin $1,814,491/day · 20d vol
- Last synced
-
2026-09-25 21:10:04
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-22 | Affeldt Eric | Buy | 42,857 | $3.50 | $150,000 | Form 4 |
| 2026-08-24 | Carlton Charles Craig | Buy | 8,250 | $6.09 | $50,242 | Form 4 |
| 2026-08-21 | Carlton Charles Craig | Buy | 7,000 | $7.13 | $49,910 | Form 4 |
| 2026-08-20 | Remy Donald Michael | Buy | 365 | $5.40 | $1,971 | Form 4 |
| 2026-08-19 | Remy Donald Michael | Buy | 540 | $5.25 | $2,835 | Form 4 |
| 2026-08-19 | Affeldt Eric | Buy | 5,000 | $5.96 | $29,800 | Form 4 |
| 2026-08-19 | Furniss Todd Anthony | Buy | 1,000 | $5.59 | $5,590 | Form 4 |
| 2026-07-07 | Glajch Jeffrey | Sell | 7,485 | $12.97 | $97,080 | Form 4 |
| 2026-07-06 | Glajch Jeffrey | Sell | 14,295 | $13.60 | $194,412 | Form 4 |
| 2026-06-30 | Liebman Stephanie | Sell | 14,780 | $14.21 | $210,024 | Form 4 |
| 2026-06-30 | Weiszhaar Barbara Barton | Sell | 14,781 | $14.21 | $210,038 | Form 4 |
| 2026-06-29 | Liebman Stephanie | Sell | 5,000 | $14.75 | $73,750 | Form 4 |
| 2026-06-29 | Weiszhaar Barbara Barton | Sell | 5,000 | $15.21 | $76,050 | Form 4 |
| 2026-06-26 | Liebman Stephanie | Sell | 1,397 | $15.62 | $21,821 | Form 4 |
| 2026-06-26 | Weiszhaar Barbara Barton | Sell | 1,397 | $15.62 | $21,821 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-25
Despite a strong M&A catalyst (Messier 42 LOI with projected $250M FCF) reinforced by meaningful insider buying, the complete absence of historical financial data, zero liquidity score, and zero fundamental trend score…
The first sentence of the analysis written for AIAI on 2026-09-25 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
No ratio data synced.
Key metrics
No metrics data synced.
Employee count
No employee-count data synced.
Peer market caps
No peer data synced.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-18 AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement Capital Contribution Requires no Consideration to be Paid DALLAS, TX / ACCESS Newswire / September 18, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its affiliated entity, Messier 42 LLC ("M42"), has agreed to contribute to the capital of the Company a controlling position in the entity holding M42''s marketing agreement for the sale of military equipment (the "Teaming Agreement"). Under this arrangement, 100% of the revenue and EBITDA generated by the M42 entity which holds the Teaming Agreement will be consolidated on the Company''s financial statements and reported by the Company and the Company will distribute approximately 50% of the resulting Free Cash Flow to M42.
- 2026-09-17 AIAI Holdings'' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare Constellation Brings Dôr''s Retail Intelligence Architecture to Healthcare Connects Clinical, Scheduling, Call-Center and Staffing Data to Predict Care Needs, Optimize Provider Capacity and Improve Patient Access DALLAS, TX / ACCESS Newswire / September 17, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance announced today that its portfolio company, Constellation Network, through Dôr Technologies, has launched Dôr Patient Journey, a new healthcare intelligence platform. Developed in collaboration with Proactive MD, the platform is actively deployed within Proactive MD''s care environment.
- 2026-09-11 AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value DALLAS, TX / ACCESS Newswire / September 11, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance announced today that it has entered into amendments to its existing lock-up agreements entered into in connection with the Company''s direct listing with holders of the Company''s outstanding shares of Class A Common Stock. The list of those signing the amendment includes the Company''s founder and Chairman, other members of the Company''s board of directors, members of management and a majority of its largest stockholders.
- 2026-09-03 AIAI Holdings Announces Letter of Intent with Messier 42 LLC to Acquire Controlling Interest in Defense & National Security Company With Projected $250M of Annual Free Cash Flow Post Closing DALLAS, TX / ACCESS Newswire / September 3, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, announced that the Company has entered into a letter of intent with its affiliated entity, Messier 42 LLC ("M42"), to acquire a controlling interest in one of M42''s businesses with operations in the defense industry. M42 projects that this business is expected to produce $250 million in Free Cash Flow during the 12 months following the closing.
- 2026-09-01 NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, announced today the appointment of Dr. Keith M.
- 2026-08-24 AIAI Holdings Commences Discussions with Messier 42 LLC Regarding Acquisition Opportunities DALLAS, TX / ACCESS Newswire / August 24, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, announced today that, following discussions with its board, the Company is commencing discussions with Messier 42 LLC, a company controlled by our founder and controlling stockholder, John P. Rochon, to begin the process of acquiring a number of M42''s existing and targeted businesses across multiple sectors to help execute the Company''s vision, including international and domestic defense, intelligence, healthcare, gaming and rare earth minerals.
- 2026-08-20 NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High TORONTO, Aug. 20, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc . (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today provided an update on recent commercial, strategic and operational developments as the Company continues to advance adoption of its proprietary NetraAI platform across the pharmaceutical and clinical-research industries.
- 2026-08-18 AIAI Holdings'' CEO Todd Furniss Issues Shareholder Letter DALLAS, TX / ACCESS Newswire / August 18, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today issues a shareholder letter from CEO Todd Furniss which can be read below. Fellow Shareholders, This is our first shareholder letter, and I am excited to share our vision and the foundation we are building for AIAI Holdings.
- 2026-08-11 AIAI Holdings'' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence Platform Connects Customer Traffic With Point-of-Sale, Labor, Marketing and Weather Data to Identify Missed Demand, Explain Performance Shifts and Recommend Next Actions Across One Location or Hundreds DALLAS, TX / ACCESS Newswire / August 11, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, Constellation Network has commercially launched Dôr Retail Intelligence, a platform for physical commerce powered by the industry''s first thermal-sensing, battery-operated people counter that is currently deployed in over 2,000 retail stores to help businesses better understand customer demand, improve operational performance and guide smarter decisions. Built upon more than a decade of customer traffic analytics, Dôr Retail Intelligence combines traffic data with point of sale, e-commerce, labor, weather and other operational information to identify missed demand, explain business performance and recommend actionable next steps.
- 2026-08-06 AIAI Holdings'' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare New service combines advanced diagnostics, predictive health intelligence and world-class physician expertise to enable earlier detection and expert resolution DALLAS, TX / ACCESS Newswire / August 6, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide, has launched its Longevity Intelligence Service, the latest advancement in its expanding precision healthcare platform. MediGuide''s Longevity Intelligence is a service designed to help individuals better understand their biological health, identify potential health risks earlier and receive personalized clinical guidance through an integrated preventive healthcare solution that combines advanced diagnostics, predictive health intelligence, physician expertise and coordinated care.